BriaCell Therapeutics Corp. (BCTX)
NASDAQ: BCTX · Real-Time Price · USD
3.610
+0.140 (4.03%)
At close: Apr 2, 2025, 4:00 PM
3.583
-0.027 (-0.76%)
After-hours: Apr 2, 2025, 5:59 PM EDT

BriaCell Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Aug - Jul.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Apr '25 Jul '24 Jul '23 Jul '22 Jul '21 Jul '20 2015 - 2019
Market Capitalization
1314106101795
Upgrade
Market Cap Growth
-78.19%-87.19%4.90%29.07%1427.05%-50.55%
Upgrade
Enterprise Value
8127757595
Upgrade
Last Close Price
3.6111.29100.3597.5076.20107.93
Upgrade
PB Ratio
4.10-5.08-28.189.822.84-1.43
Upgrade
P/TBV Ratio
4.32--10.052.87-
Upgrade
Debt / Equity Ratio
----0.00-0.11
Upgrade
Quick Ratio
1.370.2111.8043.64102.880.01
Upgrade
Current Ratio
1.370.4914.9645.00103.810.07
Upgrade
Return on Equity (ROE)
---619.75%-141.25%-114.78%-
Upgrade
Return on Assets (ROA)
-158.14%-126.11%-41.71%-18.99%-14.89%-509.24%
Upgrade
Return on Capital (ROIC)
---444.01%-50.26%-35.58%-
Upgrade
Earnings Yield
-87.53%-35.14%-19.08%-26.45%-17.58%-78.18%
Upgrade
FCF Yield
-169.53%-180.31%-22.31%-12.30%-9.86%-24.59%
Upgrade
Buyback Yield / Dilution
-58.67%-5.35%-0.81%-242.82%-533.09%-23.16%
Upgrade
Updated Mar 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q